EP2451814
Samrunnin imídasól og samsetningar sem innihalda þau til meðhöndlunar á sníklasjúkdómum, eins og t.d. mýraköldu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
9.7.2010EP published:
9.4.2014EP application number:
10733107.6
EP translation filed:
26.6.2014Grant published:
15.7.2014EPO information:
European Patent Register
Max expiry date:
8.7.2030Expiry date:
8.7.2026Next due date:
31.7.2026
Title:
FUSED IMIDAZOLES AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS E.G. MALARIA
Timeline
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
CHATTERJEE, Arnab K.Address:
San DiegoCalifornia, US
Name:
NAGLE, AdvaitAddress:
San DiegoCalifornia, US
Name:
WU, TaoAddress:
San DiegoCalifornia, US
Name:
TULLY, DavidAddress:
San DiegoCalifornia, US
Name:
KUHEN, Kelli L.Address:
Solana BeachCalifornia, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
224433 PDate:
9.7.2009Country:
US
Classification
Categories:
C07D 487/04, C07D 487/14, C07D 519/00, A61K 31/4985, A61P 33/06, A61P 33/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 10.6.2014
Expires: 8.7.2015
Payer: Árnason Faktor
Number: 6
Paid: 9.6.2015
Expires: 8.7.2016
Payer: Árnason Faktor
Number: 7
Paid: 8.6.2016
Expires: 8.7.2017
Payer: Árnason Faktor
Number: 8
Paid: 26.6.2017
Expires: 8.7.2018
Payer: Árnason Faktor
Number: 9
Paid: 27.6.2018
Expires: 8.7.2019
Payer: Árnason Faktor
Number: 10
Paid: 25.6.2019
Expires: 8.7.2020
Payer: Árnason Faktor
Number: 11
Paid: 25.6.2020
Expires: 8.7.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 24.6.2021
Expires: 8.7.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 29.6.2022
Expires: 8.7.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.6.2023
Expires: 8.7.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 24.6.2024
Expires: 8.7.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 18.7.2025
Expires: 8.7.2026
Payer: Árnason Faktor ehf.